Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52 693 patients in the Global Registry of Acute Coronary Events
Open Access
- 10 November 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 31 (4) , 430-438
Abstract
Brief episode(s) of ischaemia may increase cardiac tolerance to a subsequent major ischaemic insult (‘preconditioning’). Nitrates can pharmacologically mimic ischaemic preconditioning in animals. In this study, we investigated whether antecedent nitrate therapy affords protection toward acute ischaemic events using data from the Global Registry of Acute Coronary Events. The dataset comprised 52 693 patients from 123 centres in 14 countries: 42 138 (80%) were nitrate-naïve and 10 555 (20%) were on chronic nitrates at admission. In nitrate-naïve patients, admission diagnosis was ST-segment elevation myocardial infarction (STEMI) in 41%, whereas 59% presented with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). In contrast, only 18% nitrate users showed STEMI, whereas 82% presented with NSTE-ACS. Thus, among nitrate users clinical presentation was tilted toward NSTE-ACS by more than four-fold, STEMI occurring in less than one of five patients (P < 0.0001). After adjustment (age, sex, medical history, prior therapy, revascularization, previous angina), chronic nitrate use remained independent predictor of NSTE-ACS (OR 1.36; 95% CI 1.26–1.46; P < 0.0001). Furthermore, regardless of presentation, within both STEMI and NSTEMI populations, antecedent nitrate use was associated with significantly lower levels of CK-MB and troponin (P < 0.0001 for all). In this large multinational registry, chronic nitrate use was associated with a shift away from STEMI in favour of NSTE-ACS and with less release of markers of cardiac necrosis. These findings suggest that in nitrate users acute coronary events may develop to a smaller extent. Randomized, placebo-controlled trials are warranted to establish whether nitrate therapy may pharmacologically precondition the heart toward ischaemic episodes.Keywords
This publication has 46 references indexed in Scilit:
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevationEuropean Heart Journal, 2008
- Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategiesCardiovascular Research, 2006
- The ubiquitous role of nitric oxide in cardioprotectionJournal of Molecular and Cellular Cardiology, 2006
- Delayed Preconditioning-Mimetic Actions of Nitroglycerin in Patients Undergoing Exercise Tolerance TestsCirculation, 2005
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive SummaryCirculation, 2004
- NO Donor-Activated PKC-δ Plays a Pivotal Role in Ischemic Myocardial Protection through Accelerated Opening of Mitochondrial K-ATP ChannelsJournal of Cardiovascular Pharmacology, 2004
- Exercise-induced and nitroglycerin-induced myocardial preconditioning improves hemodynamics in patients with anginaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Sildenafil Induces Delayed Preconditioning Through Inducible Nitric Oxide Synthase–Dependent Pathway in Mouse HeartCirculation Research, 2003
- Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)**Further information about the project, along with a complete list of the study participants, can be found at www.outcomes.org/grace.The American Journal of Cardiology, 2002
- Significance of preinfarction angina for preservation of left ventricular function in acute myocardial infarctionAmerican Heart Journal, 1992